BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

491 related articles for article (PubMed ID: 15624745)

  • 1. Treatment of axillary hyperhidrosis by chemodenervation of sweat glands using botulinum toxin type A.
    Glaser DA
    J Drugs Dermatol; 2004; 3(6):627-31. PubMed ID: 15624745
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Anatomy of the sweat glands, pharmacology of botulinum toxin, and distinctive syndromes associated with hyperhidrosis.
    Kreyden OP; Scheidegger EP
    Clin Dermatol; 2004; 22(1):40-4. PubMed ID: 15158544
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of axillary hyperhidrosis with botulinum toxin type A reconstituted in lidocaine or in normal saline: a randomized, side-by-side, double-blind study.
    Vadoud-Seyedi J; Simonart T
    Br J Dermatol; 2007 May; 156(5):986-9. PubMed ID: 17286630
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Sweat gland morphology and periglandular innervation in essential palmar hyperhidrosis before and after treatment with intradermal botulinum toxin.
    Swartling C; Naver H; Pihl-Lundin I; Hagforsen E; Vahlquist A
    J Am Acad Dermatol; 2004 Nov; 51(5):739-45. PubMed ID: 15523352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Axillary injection of botulinum A toxin in a patient with muscle cramps associated with severe axillary hyperhidrosis.
    Filosto M; Bertolasi L; Fincati E; Priori A; Tomelleri G; Chieregato G; Rizzuto N
    Acta Neurol Belg; 2001 Jun; 101(2):121-3. PubMed ID: 11486559
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Botulinum toxin type a is a safe and effective treatment for axillary hyperhidrosis over 16 months: a prospective study.
    Naumann M; Lowe NJ; Kumar CR; Hamm H;
    Arch Dermatol; 2003 Jun; 139(6):731-6. PubMed ID: 12810503
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Low-dose efficacy of botulinum toxin A for axillary hyperhidrosis: a randomized, side-by-side, open-label study.
    Heckmann M; Plewig G;
    Arch Dermatol; 2005 Oct; 141(10):1255-9. PubMed ID: 16230563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Toxin treatment of sweat pearls. A review of the treatment of hyperhidrosis with a special view of a new therapy option using botulinum toxin A].
    Kreyden OP; Burg G
    Schweiz Med Wochenschr; 2000 Jul; 130(29-30):1084-90. PubMed ID: 10971942
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Botulinum toxin A for axillary hyperhidrosis (excessive sweating).
    Heckmann M; Ceballos-Baumann AO; Plewig G;
    N Engl J Med; 2001 Feb; 344(7):488-93. PubMed ID: 11172190
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [The methods of hyperhidrosis treatment].
    Woźniacka A; Bogucki A
    Pol Merkur Lekarski; 2003 Nov; 15(89):495-7. PubMed ID: 14969153
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of botulinum toxin type A in the treatment of focal axillary hyperhidrosis.
    Absar MS; Onwudike M
    Dermatol Surg; 2008 Jun; 34(6):751-5. PubMed ID: 18318723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Topically applied botulinum toxin type A for the treatment of primary axillary hyperhidrosis: results of a randomized, blinded, vehicle-controlled study.
    Glogau RG
    Dermatol Surg; 2007 Jan; 33(1 Spec No.):S76-80. PubMed ID: 17241418
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Focal hyperhidrosis: disease characteristics and treatments].
    Campanelli A; Salomon D
    Rev Med Suisse; 2009 Apr; 5(200):870-5. PubMed ID: 19438086
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prospective open-label study of botulinum toxin type A in patients with axillary hyperhidrosis: effects on functional impairment and quality of life.
    Solish N; Benohanian A; Kowalski JW;
    Dermatol Surg; 2005 Apr; 31(4):405-13. PubMed ID: 15871315
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dilution of botulinum toxin A in lidocaine vs. in normal saline for the treatment of primary axillary hyperhidrosis: a double-blind, randomized, comparative preliminary study.
    Güleç AT
    J Eur Acad Dermatol Venereol; 2012 Mar; 26(3):314-8. PubMed ID: 21492253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Type A botulinum toxin: a new treatment for axillary and palmar hyperhidrosis.
    Rusciani L; Severino E; Rusciani A
    J Drugs Dermatol; 2002 Sep; 1(2):147-51. PubMed ID: 12847738
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Skin cooling for botulinum toxin A injection in patients with focal axillary hyperhidrosis: a prospective, randomized, controlled study.
    Bechara FG; Sand M; Altmeyer P; Sand D; Hoffmann K
    Ann Plast Surg; 2007 Mar; 58(3):299-302. PubMed ID: 17471136
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Type A botulinum toxin: a new methods in treating focal hyperhidrosis. A summary of various possibilities in hyperhidrosis therapy with special emphasis type A botulinum toxin injections].
    Kreyden OP; Böni R; Burg G
    Praxis (Bern 1994); 2000 May; 89(21):909-15. PubMed ID: 10859980
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of plantar hyperhidrosis with botulinum toxin type A.
    Vadoud-Seyedi J
    Int J Dermatol; 2004 Dec; 43(12):969-71. PubMed ID: 15569036
    [TBL] [Abstract][Full Text] [Related]  

  • 20. No compensatory sweating after botulinum toxin treatment of palmar hyperhidrosis.
    Krogstad AL; Skymne A; Pegenius G; Elam M; Wallin BG
    Br J Dermatol; 2005 Feb; 152(2):329-33. PubMed ID: 15727647
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 25.